A well-defined market access strategy is essential for success in the Chinese pharmaceutical market. A good market access strategy enables pharmaceutical companies to provide safe and effective therapy to patients and realize economic success with demonstrated clinical value.
BaiPharm serves as a trusted regulatory partner, proposing a customized strategy for each product based on meticulous market research, in-depth understanding of regulations and policies, efficient communications with regulators, and close networks with industry stakeholders.
Common Challenges in Market Access
Pharmaceutical companies may find a series of challenges when seeking market access:
Limited knowledge of the regulations in the target market;
Unfamiliarity with the procurement, pricing, and reimbursement policies;
Unclear profile of the patient group and unmet needs;
Insufficient product differentiation, etc.
Our Services
Pre-Market Research
Investigating market size & trend, patient population, distribution, and needs, as well as competitive products.
Regulatory Compliance Consulting
Advice on product classification, registration strategy, CMC (chemistry, manufacturing and control) research/non-clinical/clinical, DMF filing for APIs, excipients, packaging materials, and marketing authorization application (NDA & ANDA).
Product Registration
Feasibility assessment of registration approval, data gap analysis, translation and preparation of the dossier, submission of application to CDE, response to deficiency letters, preparation of supplementary materials, and support for sample testing.
Post-Market Management
Preparing and submitting post-approval change applications, as well as renewal applications, submitting annual reports, providing China PV solutions, and offering DRP solutions for overseas MAHs.
Why Choose BaiPharm?
BaiPharm, a specialized subsidiary of REACH24H Consulting Group, is dedicated to pharmaceutical regulatory compliance. With offices in the U.S., EU, Japan, and South Korea, our expert team — including regulatory specialists, GxP auditors, consultants, certified toxicologists, and former inspectors — has supported over 600 pharmaceutical firms from 26 countries.
With extensive experience in the pharmaceutical industry and a team of regulatory professionals, BaiPharm helps you better understand regulatory requirements, stay ahead of regulatory trends, and develop professional product registration strategies.
We provide full-process Domestic Responsible Person (DRP) services and integrated global solutions for Pharmaceutical Intermediates, APIs, Excipients, Packaging Materials, Drug Products, and Medical Devices. Our offerings include Product Registration, Pharmacovigilance (PV), GxP Compliance, Regulatory Intelligence & Consulting, and Toxicological Risk Assessment, ensuring compliant, efficient, and reliable market entry.
Related REACH24H Resources and Services
Explore more BaiPharm pharmaceutical regulatory services:
Not sure where to start? Our regulatory experts are ready to help.
Email: customer@reach24h.com
浙公网安备 33011002014301号